GT Biopharma Inc (GTBP)

GT Biopharma Inc Azioni (GTBP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Selling, General, and Administrative	3.01% 1.811	1.758	1.526	2.015	2.936
Operating Income/Loss	1.47% -3.168	-3.122	-3.621	-3.665	-5.778
Nonoperating Income/Loss	70.82% 0.206	0.706	1.629	3.438	0.194
Income/Loss From Continuing Operations Before Tax	22.60% -2.962	-2.416	-1.992	-0.227	-5.584
Income/Loss From Continuing Operations After Tax	22.60% -2.962	-2.416	-1.992	-0.227	-5.584
Net Income/Loss	22.60% -2.962	-2.416	-1.992	-0.227	-5.584
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	194.47% -38.75	41.02	40.17	39.09	0.1442
Diluted Average Shares	194.47% -38.75	41.02	40.17	-0.5405	-
Basic Earnings Per Share	9,100% -5.52	-0.06	-0.05	-0.01	-0.18
Diluted Earnings Per Share	9,100% -5.52	-0.06	-0.05	-0.010	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-